Published in World J Diabetes on February 15, 2015
Factors influencing the quality of life perception in patients with type 2 diabetes mellitus. Patient Prefer Adherence (2016) 0.82
Impact of neuropathy on the adherence to diabetes-related self-care activities: a cross-sectional study. Patient Prefer Adherence (2016) 0.80
Nutrient sensing and utilization: Getting to the heart of metabolic flexibility. Biochimie (2015) 0.79
Assessment of Autonomic Dysfunction in Acute Stroke Patients at a Tertiary Care Hospital. J Clin Diagn Res (2017) 0.75
Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients. Indian J Endocrinol Metab (2016) 0.75
Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes. J Diabetes Res (2017) 0.75
Impact of Diabetes Type 1 in Children on Autonomic Modulation at Rest and in Response to the Active Orthostatic Test. PLoS One (2016) 0.75
The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey. PLoS One (2016) 0.75
Risk factors of diabetic cardiac autonomic neuropathy in patients with type 1 diabetes mellitus: a meta-analysis. Open Heart (2016) 0.75
Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis. Ther Adv Musculoskelet Dis (2016) 0.75
Assessment of vascular autonomic function using peripheral arterial tonometry. Heart Vessels (2016) 0.75
Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients. Cardiovasc Diabetol (2017) 0.75
The relationship between heart rate variability and left ventricular layer-specific deformation in uncomplicated diabetic patients. Int J Cardiovasc Imaging (2016) 0.75
Novel Measure of Autonomic Remodeling Associated with Sudden Cardiac Arrest in Diabetes. Heart Rhythm (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation (1996) 37.54
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diabetic autonomic neuropathy. Diabetes Care (2003) 6.59
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes (1996) 5.09
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 4.58
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care (2004) 4.17
Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation (1992) 3.78
The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med (1995) 3.71
The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care (1985) 3.48
The natural history of diabetic autonomic neuropathy. Q J Med (1980) 3.36
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA (2000) 3.12
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J (1978) 2.65
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev (2011) 2.61
Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med (1980) 2.59
Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord (2010) 2.47
Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care (2010) 2.43
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.42
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol (2000) 2.28
The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain (1975) 2.20
Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care (2008) 2.14
Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care (2007) 2.13
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation (1992) 2.09
Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol (1973) 2.06
Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes (2008) 2.04
Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation (1990) 2.03
Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation (1990) 2.02
Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care (2004) 1.99
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia (1991) 1.52
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Silent myocardial ischemia. Circulation (2003) 1.49
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med (1991) 1.42
Heart rate changes in diabetes mellitus. Lancet (1981) 1.39
Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol (1985) (1991) 1.36
Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev (1994) 1.35
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications (2000) 1.33
Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res (2008) 1.32
Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology (1989) 1.30
alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation (1999) 1.30
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival. N Engl J Med (1965) 1.29
Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med (2001) 1.27
Automated quantification of sympathetic beat-by-beat activity, independent of signal quality. J Appl Physiol (1985) (2001) 1.20
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J (1999) 1.18
What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res (2012) 1.17
Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res (1997) 1.15
The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia (1999) 1.11
Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol (1993) 1.11
Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation (1978) 1.07
Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes (1996) 1.07
Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes (2006) 1.07
A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest (2008) 1.04
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism (1999) 1.01
Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol (2012) 1.00
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes (1993) 1.00
Heart rate variability--current diagnosis of the cardiac autonomic neuropathy. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2014) 0.98
Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy. Am J Cardiol (2007) 0.97
Diabetic cardiomyopathy. Anadolu Kardiyol Derg (2011) 0.97
Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med (2008) 0.96
Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function. Diabetes Metab (2012) 0.96
Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol (1990) 0.95
Hypoglycemia-associated autonomic failure in diabetes. Handb Clin Neurol (2013) 0.95
Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol (1996) 0.94
Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst (1998) 0.94
Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol (1987) 0.93
Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep (2014) 0.93
Diabetic autonomic neuropathy. Handb Clin Neurol (2013) 0.92
Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria. Diabetologia (2002) 0.90
Myocardial infarction site and mortality in diabetes. Diabetes Care (1983) 0.89
Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology (2000) 0.88
Silent myocardial ischemia in patients with diabetes mellitus. Circulation (1996) 0.88
Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol (2000) 0.87
Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus. J Anesth (2010) 0.87
Elevation of serum and ventricular norepinephrine content in the diabetic rat. Res Commun Chem Pathol Pharmacol (1981) 0.87
Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia (2012) 0.86
Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes (1996) 0.86
Antioxidants and myocardial contractility: illuminating the "Dark Side" of beta-adrenergic receptor activation? Circulation (2001) 0.86
Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation. Diabetologia (1991) 0.85